Compound Detail
CHEMBL2180587
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2180587 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | GFAUOHVOSIKURI-UHFFFAOYSA-N |
5
Targets
7
Activities
2
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
439.5
MW (Da)
3.12
ALogP
6
HBA
4
HBD
116.2
PSA (Ų)
0.25
QED
0
Ro5 Violations
12
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 6.7
EC50 1 meas. best 7.57
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 7.57 | 7.57 | 27.0 | 1 |
| Human immunodeficiency virus type 1 integrase CHEMBL3471 | IC50 | 6.7 | 5.96 | 200.0 | 2 |
| HCT-116 CHEMBL394 | IC50 | 5.4 | 5.31 | 4000.0 | 2 |
| MDA-MB-435 CHEMBL614697 | IC50 | 4.8 | 4.8 | 16000.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.72 | 4.72 | 19000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus 1 | EC50 | = | 27.0 | nM | 7.57 | Antiviral activity against HIV1 3B infected in human C8166 cells assessed as red... | 23098137 |
| Human immunodeficiency virus type 1 integrase | IC50 | = | 200.0 | nM | 6.7 | Inhibition of HIV1 integrase strand transfer activity using [32P]-labeled linear... | 23098137 |
| HCT-116 | IC50 | = | 4000.0 | nM | 5.4 | Cytotoxicity against p53 expressing human HCT116 cells incubated for 72 hrs by M... | 23098137 |
| HCT-116 | IC50 | = | 6000.0 | nM | 5.22 | Cytotoxicity against p53 deficient human HCT116 cells incubated for 72 hrs by MT... | 23098137 |
| Human immunodeficiency virus type 1 integrase | IC50 | = | 6000.0 | nM | 5.22 | Inhibition of HIV1 integrase 3'-processing activity using [32P]-labeled linear o... | 23098137 |
| MDA-MB-435 | IC50 | = | 16000.0 | nM | 4.8 | Cytotoxicity against human MDA-MB-435 cells incubated for 72 hrs by MTT assay | 23098137 |
| MCF7 | IC50 | = | 19000.0 | nM | 4.72 | Cytotoxicity against human MCF7 cells incubated for 72 hrs by MTT assay | 23098137 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23098137 | 10.1021/jm300667v | HCT-116 | 2 |
| 23098137 | 10.1021/jm300667v | Human immunodeficiency virus type 1 integrase | 2 |
| 23098137 | 10.1021/jm300667v | Vascular endothelial growth factor receptor 2 | 1 |
| 23098137 | 10.1021/jm300667v | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 23098137 | 10.1021/jm300667v | Receptor tyrosine-protein kinase erbB-2 | 1 |
| 23098137 | 10.1021/jm300667v | Epidermal growth factor receptor | 1 |
| 23098137 | 10.1021/jm300667v | MCF7 | 1 |
| 23098137 | 10.1021/jm300667v | MDA-MB-435 | 1 |
| 23098137 | 10.1021/jm300667v | ADMET | 1 |
| 23098137 | 10.1021/jm300667v | C8166 | 1 |
| 23098137 | 10.1021/jm300667v | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine